Every FDA-approved weight loss medication in one place, medically reviewed and written to be understood by patients.
A new GLP-1 pill you can take with or without food. No fasting or timing needed.Approved April 2026, Foundayo works differently from earlier GLP-1 pills. Its unique formulation does not bind to food, meaning you can take it with or without a meal, any time that fits your routine.
Same results as the Wegovy shot, in pill form. Must be taken on a completely empty stomach every morning.Novo Nordisk's daily pill delivers clinical results comparable to the Wegovy injection. Dosing is strict: taken with plain water on a completely empty stomach, at least 30 minutes before your first food or drink of the day.
A diabetes pill sometimes used off-label for weight loss. Lower dose than Oral Wegovy.An oral semaglutide approved for Type 2 diabetes, also used off-label for weight loss. Lower dose than Oral Wegovy, and not the preferred choice if weight loss is your primary goal.
The original weight loss injection. FDA approved and backed by strong clinical trials.The original blockbuster GLP-1 injection. Approved specifically for weight loss and backed by the largest GLP-1 clinical trial ever run at the time of its approval.
More weight loss than any other FDA approved option. Targets two hunger hormones instead of one.Zepbound targets two hunger hormones instead of one, producing more weight loss than any other FDA approved medication. In a head to head trial it outperformed Wegovy by nearly 50% more weight loss.
Approved for diabetes but widely used off-label for weight loss. Same ingredient as Wegovy.FDA-approved for Type 2 diabetes, widely prescribed off-label for weight loss. Same active ingredient as Wegovy but at a lower approved dose.
Same molecule as Zepbound, approved for diabetes. Widely used off-label for weight loss.Same active ingredient as Zepbound (tirzepatide) but approved for Type 2 diabetes rather than weight loss. Targets two hunger hormones, producing strong results in trials.
The original GLP-1 weight loss injection. Daily shot with more modest results than newer options.The first GLP-1 specifically approved for weight loss in 2014. Daily injection, more modest results than newer semaglutide and tirzepatide options, but still clinically meaningful.
A weekly GLP-1 injection for diabetes, also used off-label for weight loss.An older weekly GLP-1 injection approved for type 2 diabetes. Well-established safety record since 2014, with more modest weight loss than newer semaglutide and tirzepatide options.